chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Employee has history of receiving three documented doses of hepatitis B vaccine on 9/23/06, 5/6/08 and 1/3/09. A borderline HBsAB was drawn on 7/26/16. Booster dose of Hepatitis B vaccine was administered of 8/19/16. Medical history reported by employee includes HTN and pre-diabetes. His daily medications include ASA 81 mg, MV, Vitamin B, WELLBUTRIN and Lisinopril. Employee came in today for follow up HBsAB which was drawn; results are pending. Employee reports the following symptoms and events following the hepatitis B vaccine administered on 8/19/16. One week after receiving the hepatitis B vaccine employee reported pain and stiffness in lower extremity joints. Four weeks later after playing golf, he felt pain and stiffness in back and shoulders that was acute and nearly incapacitating. Bilateral pain and stiffness in shoulders, back and hips continued with increased immobility, pain, stiffness, and fatigue. During the week of October 17 symptoms worsen along with severe muscle spasms throughout pelvic area. Trouble with ADLs included: getting in and out of bed, getting in and out of the shower, independently dressing and toileting, getting in and out chairs and climbing up and down stairs. Employee went to urgent care on October 20 after being incapacitated. Hips x-rays were taken with negative results. Labs were all normal except for a high C reactive protein and elevated sedimentation (ESR). NSAIDs and skeletal muscle relaxants were prescribed. Employee was unable to work October 24-26 and 28 with fever on October 26-28. PCP appointment on October 26; prednisone was prescribed and referral made to rheumatologist. Since starting the prednisone pain and stiffness in joints has lessened with onset of numbness and tingling present in both legs and feet. Continued pain bilaterally in both shoulders, hands, low back and knees. Employee is currently waiting to see a rheumatologist.
Patient was given Moderna second dose. Patient was 17 at the time of injection. Patient tolerated well, no adverse reactions.
I couldn't sleep, I was very tired but I couldn't sleep.  My head was throbbing , felt like it would burst.  My blood pressure went up to 170/93.  Ached all over rest of body.
Went to ER, was given steroids, breathing treatment and IV. Started with high fever.
Headache; This is a spontaneous report from a contactable nurse. This nurse reported similar event for six patients. This is 5th out of six reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm on 29Dec2020 at single dose for an COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient worked in a healthcare facility and had not had COVID. The patient experienced headache on 04Jan2021 with outcome of not recovered. Treatment: none. Drug result: related.  Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021006274 same reporter/ drug , different patient /AE.
Information regarding Flumist (2003-2004 Formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from the father of an 8 year old male who experienced headache, fever up to 103 deg. F., fatigue and cough.  At 8 years of age, the child received a dose on 12/15/03.  The reporter indicated that the child experiences "something similar with cough and fever every winter."  Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 12/15/03. Dose regimen was 1 dose (IN).  Pt was not taking concomitant therapy. The pt experienced headache (headache, fever up to 103 deg. F. (pyrexia), fatigue (fatigue) and cough (cough) on 12/20/03.  The child was treated with ibuprofen.  As of 12/22/03, the headache and fever were much better but the child is still fatigued.  No additional information was available at the time of this report.
I was having strange heart palpitation.  i had really bad gas that caused heart racing, vomiting all the way until the 4/20/21. I starting feeling better 21st and I was at 100 percent on the 6th of May
Pt presented today with a red rash on chest, neck and arms. The rash was not itching or causing pain to patient just more annoying in appearance. Patient was advised to begin Diphenhydramine if rash worsens, but patient was resistant to start because of possible drowsiness.
Pt recvd 3 doses of Engerix-B vax on 23JAN91, 20FEB91, & 10JUL91 & on 29OCT91 pos HBSAB was 0.0 RU which is interpreted as neg (no immunity);
Patient return to office with swelling, erythema and exanthema to right upper thigh after vaccines administered on 9/10/18. Mother denied patient having any fever, chills, vomiting, diarrhea or difficulty breathing. Patient was prescribed TYLENOL and hydroxyzine. Advised mother to RTO if rash does not resolve in 7-10 days.
Pt came in 4/28/21 stated he experienced tightness in the face that lasted 1 day, He did not experience fainting or dizines. Called pt on several occasion to followup after 2nd dose. no response
The child received vaccines at 13m of age, mom states that shortly after that, he had regression. He stopped talking. Per records, a visit at 20 months he appeared to be developing well, however.
Chills, nausea, rash starting on stomach, spreading to face, legs then arms.  Fever of 99 degrees and swollen glands on neck.
Local erythema 4X3cm diam, 3cm under injection site. C/O minor discomfort.
Patient was at clinic with mom getting catch-up vaccines. Vaccine was ordered correctly on chart. MA when to look for vaccines and did not realize it was the adult vaccine vs. the pediatric vaccine. Administered adult vaccine instead of pediatric
Severe insomnia for 11 days, irregular heart rate, palpitations, sustained itching at injection site for 11 days and itching across chest (no rash)
patient received the wrong  booster type -- patient received Pfizer pediatric dose instead of adult dose
severe pain in both legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in both legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (severe pain in both legs). The patient was treated with PARACETAMOL (TYLENOL) for Leg pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (severe pain in both legs) had not resolved. Not Provided          No concomitant medications were reported.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments Action taken with mRNA-1273 in response to the event was not applicable.
This case was reported by a physician and described the occurrence of low seroconversion to hepatitis B in a subject of unspecified age and gender who was vaccinated with Engerix B (GlaxoSmithKline) for prophylaxis.  On an unspecified date the subject received unspecified dose of Engerix B (unknown).  At an unspecified time after vaccination with Engerix B, the subject experienced low seroconversion to hepatitis B vaccine.  At the time of reporting the outcome of the event was unspecified.
late second doses/first dose on March 2020; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as an adult as per vaccine indication. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No information about lot number or patient details at the moment of the call. The reporter consented to follow up by email. This case has been linked with case US2021AMR077350, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR077350:Same reporter, different patient
This spontaneous report was received from a licensed practical nurse and refers to unspecified number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions and allergies were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (route was not reported) lot # M009378 and expiry date: 23-APR-2018, 0.5 ml, for prophylaxis. The reporter stated that she was unaware of any adverse effects reported. The call was due to a data logger. No further information was available. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Follow-up information has been received on 07-DEC-2016. All telephone attempts to obtain follow-up information has been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1610USA009508: US-009507513-1610USA009509: US-009507513-1610USA009510: US-009507513-1610USA009506: US-009507513-1610USA009505: US-009507513-1610USA009507: MERCK 1610USA008210:Mfr number.
I had a bad headache then I started having a cough which was different from the usual one I have. Some sore throat that wasn't horrible, I felt sick for 2 days and then was fine. I took Paxlovid for 5 days. The symptoms were bad for 2 days, my oxygen rate was down to 92% and it's usually 95%.
Patient started to feel dizzy at around 4:00 am and went back to sleep.  He got up around 9:30 am and felt dizzy.  Blood pressure was 156/102.  He then rested for about an hour. At around 10:40, he did some light exercise, playing  tennis and he felt better at around 11:00 am.
Case number PHEH2015US025186, is an initial spontaneous report received from a medical assistant on 01 Dec 2015. This report refers to a 61-year-old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 173538) at a dose of 0.5 ml intramuscularly on 16 Oct 2015 which was stored out of temperature range first time at 32 Fahrenheit and second time at 48.7 Fahrenheit. No adverse event was reported following this medication error.
Intermittent chills lasted 10 days. Intermittent low grade headache lasted 8 days, Severe skin rash / spots ongoing, but  slowly going away. Joint pain, Very low energy ongoing.
Pt was to receive moderna bivalent booster, however, also received moderna original at full dosing (0.5 ml).  Pt had no adverse effects for following 15 minutes and stated was okay to return home.  Pt will be followed up with in 24 hours.
Contracted COVID-19 (rapid test used to verify).  Treated with rest, over the counter medications, and Paxlovid.  Symptoms improved after 3 days, no symptoms after 4 days, still testing positive at 6 days.
Diarrhea starting approximately 10 hours after administration and continuing up to time of this report.  Treatment with OTC Loperamide provided only moderate relief for short periods of time..  Followed normal hydration recommendations to prevent dehydration.  Nausea and stomach cramping started approximately 24 hours after administration and continue up to time of this report.  Treatment of stomach cramping with Dicyclomine prescribed by GI for previous issues due to Crohn's Disease provided only moderate relief.  Nausea untreated.   Combination of symptoms led to anorexia  and I am only able to tolerate small amounts of  foods such as broth.  GI doctor was contacted on 6/23/2021 and informed of symptoms with the objective of being prescribed stronger medications to control them.  As of this report I have not received notification of any medications prescribed and awaiting me at pharmacy.
shingles 'til AFTER getting that shingles shot/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient brother/sister. The age at vaccination was not reported. The patient never had the shingles till after getting that shingles shot. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and time to onset and laboratory confirmation for shingles were unknown.
Pt states noticed bumps on arm on 8/14/08. On 8/15/08 had hives to arms, face, neck and back. Started having difficulty breathing and went to physician. Was given an injection in left hip along with Xyzal PO. Also taking Benadryl. Advised not to get another Hepatitis B shot.
Child was placed on vaccine schedule and team was rushed, vaccine was administered per LPN.  Child has been checked on daily and has not experienced adverse symptoms, and parent (mom) has been made aware of incident.
Information has been received from a female licensed practical nurse who on an unspecified date was vaccinated SC with a dose of ZOSTAVAX. Subsequently the patient noticed that the injection site felt hard for several days. Medical attention was not sought. No other symptoms were noted. Subsequently, the patient recovered. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Less than an hour after receiving the vaccine, I noticed red spots on my vaccine arm which resembled bug bites (but weren't bug bites). I had around 8 or 10 of these spots, including one on what I assume was my exact vaccination site. I am reporting these because they don't match the images I've googled. - I took photos (which I still have) and sent them to my doctor's office. He responded through a nurse that they were "possibly bug bites" and went home for the weekend. They weren't bug bites! It's been around 48 hours. The marks have faded, although the larges ones are still visible. The one directly on my vaccination site disappeared first. I'm still alive, so that's good!
Developed symptoms chest pressure, numbness and tingling left side of body.  To be seen in ER.  Released from ER - improved.
Hot sensations all over body, dizziness, light headed, shortness of breath, convulsions ? main episode lasted about 5 minutes. After that, continued light headedness and shaking. Tremors in extremities. Left chest pain/pinching sensations
22 year old received Janssen vaccine at 10:50 am, and while in recovery area, reported that he became light headed, dizzy, and passed out.  He slumped out of the chair hitting the right side of his head on the floor. Sustained a cut near his right eye. At 10:56 am blood pressure @140/65, pulse @ 53,  97% O2 sats while sitting on the floor.  EMS was called 10:57am. When interacting with staff and friend accompanying him, eye was cleaned and ice applied.  EMS arrived 11:05am. EMS reported vitals to be 86/49, 59, 100% O2.  EMS recommended transport to client. Client accepted. EMS transported to Medical Center  at 11:12 am.
REFIERE MADRE NIÑA PRESENTO FIEBRE Y DOLOREN EL BRAZO IZQUIERDO, AREA INFLAMADA EN EL AREA DE LA ADMINISTRACION DE LA  VACUNA QUADRACEL & FLUARIX DESDE EL DIA DEL EVENTO.
Mar 26, 2009@09-43 from pt. States he was in this office yesterday, received pneumonia vaccine in rt arm. Report this was he second pneumonia vaccine. States approx 3 hours after receiving vaccine, his arm began to swell. Reports arm is swollen and painful. Denies red streaks. Denies fever. Denies difficulty breathing or swallowing. Denies rash. Symptoms: .1. swelling of injected arm
Mom returned to clinic 2d after vaccination & voiced pt had been to ER for febrile seizure post vaccination.
Patient is a lovely 70 y.o. female who presents to the ED after a fall from standing height onto her living room floor while she was going to the bathroom this morning. She appears in pain, only complains of shoulder pain. She is confused and not oriented to time. She remembers getting up quickly and losing her balance. She is not sure if she hit her head or lost consciousness. She has a history of a few falls and she also suffers from breast cancer and has undergone radiation therapy. She complains of 10/10 shoulder pain since the fall. This patient denies any pertinent past medical or psychiatric history and additionally has a completely negative systems review including no nausea, vomiting, fever, chills, dysuria, diarrhea ,headache or any other symptoms of concern. Overall this patient appears well and has a reassuring presentation.
She was given Pfizer vaccination  and immediately developed facial swelling and throat tightness. She was treated with Benadryl and observed. She came to my office for an allergy consult. Discussed avoiding second dose of vaccine. She complained of paresthesia's and recommended neurology evaluation.
Bilateral lower extremity weakness x 4 days approximately 3 weeks after receiving vaccination. Approximately 3 weeks after vaccination she noticed a numb (thick) sensation in her toes. In the ensuing days the numbness ascended to her knees and began to involve the forearms and hands as well as her lips. Concurrent with the numbness  or shortly thereafter, the limbs also became weak. She has also noted some weakness with speaking. She reports having some accidents with urinating and no recent bowel movements. She reports feeling short of breath.  Reduced knee reflexes, subjective loss of sensation in a stocking and glove pattern.Considerable give-way weakness and apparent reduced effort; with encouragement and full effort, she was able to give 5/5 strength in all muscle groups.
Sore arm; she received expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (she received expired vaccine) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001821A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (she received expired vaccine). On 19-Mar-2021, EXPIRED PRODUCT ADMINISTERED (she received expired vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021A21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.     On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Jul-2020 and the estimated date of delivery was 08-Apr-2021. On 06-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were  reported. No treatment information was provided.
Febrile seizure occurred. Lasted about 1-2 minutes. Patient was transported by EMS to emergency room; fever of 103. Lasted 2 days. also with caudal erythematous rash. Now well.
Pt recvd 3 doses of Engerix-B & did not seroconvert; Booster doses were administered; no tx was given;
adult given pediatric dose; adult given pediatric dose; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a adult patient who received HBV (Engerix B pediatric) for prophylaxis.   On 21st March 2022, the patient received Engerix B pediatric. On 21st March 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   GSK Receipt Date: 24-MAR-2022 Reporter's Comment:  The registered pharmacist reported that adult patient was given pediatric dose of Engerix B. The health care professional gave fax number as contact address. The reporter consented to follow up. Additional supportive information:  The adult patient received pediatric dose of Engerix B, which led to underdose and adult use of a child product. This case was 1 of 3 cases reported by the same reporter..; Sender's Comments:  US-GLAXOSMITHKLINE-US2022053923:Same reporter US-GLAXOSMITHKLINE-US2022AMR054854:Same reporter
Initial case received from a consumer on 25 October 2012. A female patient age 77 received a dose of FLUZONE, Lot # reported as UH319AD, (to be confirmed) intramuscularly in the left side, site to be confirmed on 13 September 2012. The patient had a history of penicillin allergy, reported as PCN, diabetes, hypertension reported as HTN, high cholesterol and a history of shingles. Concomitant medications and lab results were not reported. On 15 September 2012, the patient experienced a hurting itch on face and in hair with small bumps and it spread to the side of her neck. The patient was seen by an allergist on 18 September 2012 and was diagnosed with shingles. The patient was prescribed prednisone and an unspecified shingles medicine. No further details were available at the time of this report. The patient outcome was not reported. Documents held by sender: None.
Experienced bouts of mild vertigo lasting around 5 seconds a few times a day starting after the second or third day of vaccine.  By the weekend it hadn?t gotten worse to the point where I couldn?t leave the bedroom due to the walls literally spinning. That?s as the worst day then it progressively lessened until it went away by the second week.  Thought it was worth a mention.  My gf that I live with has also had ringing in her ear non stop since the second vaccine, so I?m a little concerned about the second shot.
Rash on my side?moving to my back and other side  after 4 days of getting the vaccine   The rash was painful and itchy It?s been over 30 days .